# Pancoronavirus Vaccine Study in Healthy Adults

> **NCT06950177** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Duke University** · enrollment: 51 (estimated)

## Conditions studied

- COVID-19 Respiratory Infection
- SARS CoV 2 Infection
- COVID-19 Vaccine

## Interventions

- **BIOLOGICAL:** CoV-RBD-scNP-001 and 3M-052-AF

## Key facts

- **NCT ID:** NCT06950177
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-08
- **Primary completion:** 2026-08-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06950177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06950177, "Pancoronavirus Vaccine Study in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06950177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*